Literature DB >> 29773412

Athlete's Heart: Is the Morganroth Hypothesis Obsolete?

Mark J Haykowsky1, T Jake Samuel2, Michael D Nelson2, André La Gerche3.   

Abstract

In 1975, Morganroth and colleagues reported that the increased left ventricular (LV) mass in highly trained endurance athletes versus nonathletes was primarily due to increased end-diastolic volume while the increased LV mass in resistance trained athletes was solely due to an increased LV wall thickness. Based on the divergent remodelling patterns observed, Morganroth and colleagues hypothesised that the increased "volume" load during endurance exercise may be similar to that which occurs in patients with mitral or aortic regurgitation while the "pressure" load associated with performing a Valsalva manoeuvre (VM) during resistance exercise may mimic the stress imposed on the heart by systemic hypertension or aortic stenosis. Despite widespread acceptance of the four-decade old Morganroth hypothesis in sports cardiology, some investigators have questioned whether such a divergent "athlete's heart" phenotype exists. Given this uncertainty, the purpose of this brief review is to re-evaluate the Morganroth hypothesis regarding: i) the acute effects of resistance exercise performed with a brief VM on LV wall stress, and the patterns of LV remodelling in resistance-trained athletes; ii) the acute effects of endurance exercise on biventricular wall stress, and the time course and pattern of LV and right ventricular (RV) remodelling with endurance training; and iii) the value of comparing "loading" conditions between athletes and patients with cardiac pathology.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Athlete’s heart; Morganroth hypothesis; Wall stress

Mesh:

Year:  2018        PMID: 29773412     DOI: 10.1016/j.hlc.2018.04.289

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  6 in total

Review 1.  Athlete's Heart: Diagnostic Challenges and Future Perspectives.

Authors:  Carlo De Innocentiis; Fabrizio Ricci; Mohammed Y Khanji; Nay Aung; Claudio Tana; Elvira Verrengia; Steffen E Petersen; Sabina Gallina
Journal:  Sports Med       Date:  2018-11       Impact factor: 11.136

2.  Authors' Reply to Kindermann et al.'s Comment on: "Athlete's Heart: Diagnostic Challenges and Future Perspectives".

Authors:  Carlo De Innocentiis; Fabrizio Ricci; Mohammed Y Khanji; Nay Aung; Claudio Tana; Elvira Verrengia; Steffen E Petersen; Sabina Gallina
Journal:  Sports Med       Date:  2019-03       Impact factor: 11.136

3.  Weight Gain, Hypertension, and the Emergence of a Maladaptive Cardiovascular Phenotype Among US Football Players.

Authors:  Jonathan H Kim; Casey Hollowed; Chang Liu; Ahmed Al-Badri; Ayman Alkhoder; Morgan Dommisse; Zaina Gowani; Arthur Miller; Parker Nguyen; Ganesh Prabakaran; Arianna Sidoti; Mohamad Wehbe; Angelo Galante; Carla L Gilson; Craig Clark; Yi-An Ko; Arshed A Quyyumi; Aaron L Baggish
Journal:  JAMA Cardiol       Date:  2019-12-01       Impact factor: 14.676

4.  Sex Matters: A Comprehensive Comparison of Female and Male Hearts.

Authors:  Sarah R St Pierre; Mathias Peirlinck; Ellen Kuhl
Journal:  Front Physiol       Date:  2022-03-22       Impact factor: 4.566

5.  Normative Values for Sport-Specific Left Ventricular Dimensions and Exercise-Induced Cardiac Remodeling in Elite Spanish Male and Female Athletes.

Authors:  Araceli Boraita; Leonel Díaz-Gonzalez; Alejandro Santos-Lozano; Alejandro Lucia; Pedro L Valenzuela; María-Eugenia Heras; Francisco Morales-Acuna; Adrián Castillo-García; María J Lucia; Pedro Suja
Journal:  Sports Med Open       Date:  2022-09-15

6.  Scaling left ventricular mass in adolescent female soccer players.

Authors:  Diogo V Martinho; João Valente-Dos-Santos; Manuel J Coelho-E-Silva; Arturo O Gutiérrez; João P Duarte; Pedro Lourenço-Farinha; Leonardo G O Luz; João Gonçalves-Santos; Dalmo R L Machado; Neiva Leite; Jorge Conde; Joaquim M Castanheira; Sean P Cumming; Lauren B Sherar; Robert M Malina
Journal:  BMC Pediatr       Date:  2020-04-13       Impact factor: 2.125

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.